Public-data pharma intelligence

Custom pharma intelligence platforms,built on public data.

Source-linked. Deterministic-first. AI-supported. Human review required.

What pharma intelligence question do you want to scope?

Already exploring a platform?

Specification workspace

Scope your intelligence platform.

Start with a research question. Lippershey suggests the source map, preset filters, harmonized values, analytics modules, and review layers needed for a source-linked dashboard.

Sources determine values. Values determine filters. Value types determine analytics.

Your selected sources define which values can be harmonized. Harmonized values become dashboard filters. Value types determine which analytics features and AI review roles are relevant.

Confidence is shown as High / Medium / Low based on source coverage, contradiction prompts, and field completeness. Lippershey avoids false-precision percentages in public previews.

Which question do you want to answer?

Start with the decision or research question you want to explore. Lippershey will use it to suggest source packages, harmonized values, analytics features, and review agents.

Examples:

Intelligence specification

Draft

Selected question

Your research question will appear here.

Source package

—

Preset dashboard filters

Therapeutic areaGeographyTime windowSponsor / organizationAsset / productEvidence typeRegionPeriodStatusSource

Harmonized filters

Asset / moleculeIndicationSponsor / company

Output format

—

Transparency settings

Show source links
Show confidence labels
Show missing evidence
Show method notes

Human review

Outputs must be reviewed and validated by the user before use. Lippershey surfaces public-data intelligence; it does not make decisions or provide professional advice.

Specification only. Not a live dashboard.

Check how your dashboard looks

Preview the dashboard layout, filter bar, and modules generated from your selections.

Portfolio

Intelligence platforms for strategic pharma questions.

Each platform is built around a specific research question, sourced from public registries, and scoped for analyst and strategy teams.

01 · Platform

OFA

Oncology Failure Atlas

Live

Why oncology trials terminate and which sponsors show repeated discontinuation patterns.

Key sources

ClinicalTrials.govPubMedFDA

ExternalExplore

02 · Platform

Patent Cliff Monitor

Pilot

Which assets face exclusivity loss across therapeutic areas and time horizons.

Key sources

Patent registersFDA labelsEMA

Pilot enquiryRegister pilot interest

03 · Platform

PharmaTech Atlas

Pilot

Where evidence momentum is building across pharma and biotech technology classes.

Key sources

PubMedPatentsCompany disclosures

Pilot enquiryRegister pilot interest

04 · Platform

AccessWatch EU

Coming soon

Where European HTA, reimbursement, and policy signals shift access dynamics.

Key sources

EMA / EPARHTA bodiesScientific literature

Pilot enquiryNotify me

Check full portfolio

Methodology & transparency

Every source named. Every rule traceable.

A deterministic, source-linked pipeline with an AI interpretation layer. Outputs require user review before use. Transparency is part of the product, not a footnote.

Public sources

Every input comes from a named public registry, agency, or peer-reviewed source.

Deterministic rules

Rule-based logic runs first. Outcomes are reproducible from inputs.

AI-supported interpretation

Models add summarization and context, never replace deterministic logic.

Human review required

Outputs must be reviewed and validated by the user before use. Lippershey surfaces public-data intelligence; it does not make decisions or provide professional advice.

Missing evidence shown

Gaps and unknowns are surfaced — not hidden behind a confident answer.

No black-box claims

Sources, rules, and assumptions remain visible end-to-end.

Ways to work together

Three ways to put Lippershey to work.

From portfolio access to fully custom intelligence platforms — scoped honestly, priced well below incumbent providers.

Public portfolio access

Use the live and forthcoming portfolio platforms for clinical-failure intelligence, patent-cliff monitoring, and access signals.

See the portfolio

Pilot intelligence build

Co-scope a focused pilot on a single research question, with a defined source package and a short delivery window.

Discuss a pilot

Custom platform build

Scope a fully tailored intelligence platform around your question, sources, filters, and output format.

Request a build

Custom build

Ready to turn public data into decision-grade intelligence?

Request a custom build

No medical, investment, or regulatory advice.